Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.
Life Science REIT PLC (LABS) - Total Assets
Latest total assets as of June 2025: GBX374.95 Million GBX
Based on the latest financial reports, Life Science REIT PLC (LABS) holds total assets worth GBX374.95 Million GBX as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Life Science REIT PLC - Total Assets Trend (2021–2024)
This chart illustrates how Life Science REIT PLC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Life Science REIT PLC - Asset Composition Analysis
Current Asset Composition (December 2024)
Life Science REIT PLC's total assets of GBX374.95 Million consist of 1.4% current assets and 98.6% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 1.4% |
| Accounts Receivable | GBX7.84 Million | 2.0% |
| Inventory | GBX0.00 | 0.0% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Life Science REIT PLC's current assets represent 1.4% of total assets in 2024, a decrease from 46.2% in 2021.
- Cash Position: Cash and equivalents constituted 1.4% of total assets in 2024, down from 45.9% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 2.0% of total assets.
Life Science REIT PLC Competitors by Total Assets
Key competitors of Life Science REIT PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Al Aqar Healthcare Reit
KLSE:5116
|
Malaysia | RM1.85 Billion |
|
Aedifica SA
PINK:AEDFF
|
USA | $6.48 Billion |
|
American Healthcare REIT, Inc.
NYSE:AHR
|
USA | $4.77 Billion |
|
Assura Plc
PINK:ARSSF
|
USA | $3.28 Billion |
|
Cofinimmo SA/NV
PINK:CFMOF
|
USA | $6.43 Billion |
|
Community Healthcare Trust Inc
NYSE:CHCT
|
USA | $990.76 Million |
|
Care Property Invest NV
BR:CPINV
|
Belgium | €1.39 Billion |
|
Care REIT plc
LSE:CRT
|
UK | GBX667.29 Million |
Life Science REIT PLC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Life Science REIT PLC generates 0.05x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Life Science REIT PLC is currently not profitable relative to its asset base.
Life Science REIT PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 17.76 | 109.76 |
| Quick Ratio | 1.00 | -1.34 | -0.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX5.00K | GBX 23.84 Million | GBX 165.42 Million |
Life Science REIT PLC - Advanced Valuation Insights
This section examines the relationship between Life Science REIT PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.40 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -2.3% |
| Total Assets | GBX401.19 Million |
| Market Capitalization | $16.05K USD |
Valuation Analysis
Below Book Valuation: The market values Life Science REIT PLC's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Life Science REIT PLC's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Life Science REIT PLC (2021–2024)
The table below shows the annual total assets of Life Science REIT PLC from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | GBX401.19 Million | -2.32% |
| 2023-12-31 | GBX410.70 Million | -8.29% |
| 2022-12-31 | GBX447.82 Million | +23.91% |
| 2021-12-31 | GBX361.40 Million | -- |